In TNBC lesions, PD‐L1 is predominantly located on tumor‐infiltrating immune cells and typically inhibits antitumour immune responses, so the spatial distribution and interactions of cells in the TIME influence the efficacy of immunomodulators.6, 7, 8. This evidence concerns the gene CD274 and neoplasm.